Arrhythmogenic Right Ventricular Cardiomyopathy
Summary
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart muscle disease where the muscle of the right ventricle (and sometimes left ventricle) is gradually replaced by fat and fibrous tissue. Think of your heart muscle as strong, contractile tissue—in ARVC, this tissue is replaced by fat and scar tissue, making the heart wall weak and prone to dangerous arrhythmias (ventricular tachycardia, ventricular fibrillation). This condition is inherited (autosomal dominant) and is a leading cause of sudden cardiac death in young people, especially athletes. The disease usually presents in young adults (20-40 years) with symptoms like palpitations, syncope (fainting), or sudden cardiac arrest. The key to management is recognizing the condition (especially in young people with arrhythmias or family history), confirming the diagnosis (ECG, echocardiography, cardiac MRI, genetic testing), preventing sudden death (ICD implantation), treating arrhythmias (medications, ablation), and screening family members. This is a serious condition that requires lifelong management and monitoring.
Key Facts
- Definition: Genetic cardiomyopathy with replacement of heart muscle by fat and fibrous tissue
- Incidence: Rare (~1 in 5,000), but important cause of sudden cardiac death
- Mortality: High risk of sudden cardiac death if not treated
- Peak age: Young adults (20-40 years)
- Critical feature: Ventricular arrhythmias, risk of sudden cardiac death
- Key investigation: ECG, echocardiography, cardiac MRI, genetic testing
- First-line treatment: ICD implantation (prevent sudden death), antiarrhythmics, family screening
Clinical Pearls
"Think of it in young people with VT" — ARVC should be considered in young people (especially athletes) presenting with ventricular tachycardia or sudden cardiac arrest. It's a leading cause of sudden cardiac death in the young.
"Family history is key" — ARVC is inherited (autosomal dominant). Always ask about family history of sudden cardiac death, especially in young relatives.
"ECG shows characteristic changes" — The ECG often shows T wave inversions in V1-V3, epsilon waves, and ventricular arrhythmias with left bundle branch block pattern (originating from right ventricle).
"ICD is life-saving" — Implantable cardioverter-defibrillator (ICD) implantation is essential to prevent sudden cardiac death. This is the most important treatment.
Why This Matters Clinically
ARVC is a leading cause of sudden cardiac death in young people, especially athletes. Early recognition (especially in young people with arrhythmias or family history), proper diagnosis, and ICD implantation can prevent sudden death. This is a condition that cardiologists need to recognize and manage, as it requires lifelong monitoring and treatment.
Incidence & Prevalence
- Overall: Rare (~1 in 5,000 population)
- Trend: Increasing recognition (previously underdiagnosed)
- Peak age: Young adults (20-40 years)
Demographics
| Factor | Details |
|---|---|
| Age | Peak 20-40 years (young adults) |
| Sex | Slight male predominance |
| Ethnicity | No significant variation |
| Geography | Worldwide, some regional variations |
| Setting | Cardiology clinics, sports medicine |
Risk Factors
Non-Modifiable:
- Genetic (autosomal dominant inheritance)
- Family history of ARVC or sudden cardiac death
- Male sex (slight)
Modifiable:
| Risk Factor | Relative Risk | Mechanism |
|---|---|---|
| Exercise | 2-5x | May accelerate disease, trigger arrhythmias |
| Competitive sports | 3-5x | High-intensity exercise risk |
| Family history | 10-20x | Genetic inheritance |
Common Presentations
| Presentation | Frequency | Typical Patient |
|---|---|---|
| Sudden cardiac arrest | 20-30% | Young athlete, first presentation |
| Ventricular tachycardia | 30-40% | Young adult, palpitations |
| Syncope | 20-30% | Young adult, fainting |
| Family screening | 10-20% | Family member of known case |
The Disease Mechanism
Step 1: Genetic Mutation
- Inherited: Autosomal dominant (50% chance of passing on)
- Gene mutations: Multiple genes involved (desmosomal proteins)
- Result: Defective cell-to-cell connections
Step 2: Myocyte Death
- Cell death: Heart muscle cells die
- Replacement: Fat and fibrous tissue replace muscle
- Result: Heart wall becomes weak, thin
Step 3: Arrhythmogenic Substrate
- Scar tissue: Creates areas that can cause arrhythmias
- Weak wall: Right ventricle dilates, becomes weak
- Result: Prone to ventricular arrhythmias
Step 4: Clinical Manifestation
- Arrhythmias: Ventricular tachycardia, ventricular fibrillation
- Heart failure: If severe (right heart failure)
- Sudden death: If arrhythmia not treated
Step 5: Progression
- Gradual: Disease progresses over years
- Left ventricle: May also be affected (later)
- Result: Progressive heart failure
Classification by Stage
| Stage | Definition | Clinical Features |
|---|---|---|
| Concealed | Early, no symptoms | May have ECG changes, no symptoms |
| Overt | Symptoms present | Arrhythmias, syncope |
| Heart failure | Advanced, heart failure | Right heart failure, may have left heart failure |
Anatomical Considerations
Right Ventricle:
- Thin wall: Normally thinner than left ventricle
- In ARVC: Becomes even thinner, dilated
- Fat infiltration: Fat replaces muscle
Why Right Ventricle First:
- Thinner wall: More vulnerable
- Higher stress: In some conditions
- Genetic factors: Desmosomal proteins more important in right ventricle
Symptoms: The Patient's Story
Typical Presentation:
History:
Signs: What You See
Vital Signs (Usually Normal Unless Arrhythmia):
| Sign | Finding | Significance |
|---|---|---|
| Temperature | Usually normal | Usually normal |
| Heart rate | May be irregular (if arrhythmia) | Arrhythmia |
| Blood pressure | Usually normal (may be low if arrhythmia) | Usually normal |
General Appearance:
Cardiovascular Examination:
| Finding | What It Means | Frequency |
|---|---|---|
| Irregular pulse | Arrhythmia | If arrhythmia present |
| Heart failure signs | Right heart failure (elevated JVP, peripheral edema) | If advanced |
| Murmurs | Usually not | Usually not |
Signs of Complications:
Red Flags
[!CAUTION] Red Flags — Immediate Escalation Required:
- Sudden cardiac arrest — Medical emergency, needs urgent resuscitation, ICD
- Ventricular tachycardia — Medical emergency, needs urgent treatment, ICD
- Syncope — Needs urgent assessment, may need ICD
- Family history of sudden cardiac death — High risk, needs assessment
- Signs of heart failure — Needs assessment, treatment
Structured Approach: ABCDE
A - Airway
- Assessment: Usually patent
- Action: Secure if compromised
B - Breathing
- Look: Usually normal (may have difficulty if heart failure)
- Listen: Usually normal
- Measure: SpO2 (usually normal)
- Action: Support if needed
C - Circulation
- Look: May have signs of heart failure (elevated JVP, peripheral edema)
- Feel: Pulse (may be irregular), BP (usually normal)
- Listen: Heart sounds (usually normal, may have S3 if heart failure)
- Measure: BP (usually normal), HR (may be irregular)
- Action: Monitor if arrhythmia
D - Disability
- Assessment: Usually normal
- Action: Assess if syncope
E - Exposure
- Look: Cardiovascular examination
- Feel: JVP, peripheral pulses
- Action: Complete examination
Specific Examination Findings
Cardiovascular Examination:
- JVP: May be elevated (if right heart failure)
- Heart sounds: Usually normal (may have S3 if heart failure)
- Peripheral pulses: Usually normal (may be irregular if arrhythmia)
- Peripheral edema: May have (if right heart failure)
Special Tests
| Test | Technique | Positive Finding | Clinical Use |
|---|---|---|---|
| ECG | 12-lead ECG | T wave inversions V1-V3, epsilon waves, VT | Diagnostic |
| Echocardiography | Ultrasound of heart | Right ventricle dilation, dysfunction | Diagnostic |
| Cardiac MRI | MRI of heart | Fat infiltration, right ventricle changes | Diagnostic |
First-Line (Bedside) - Do Immediately
1. ECG (Essential)
- Purpose: Shows characteristic changes
- Finding: T wave inversions in V1-V3, epsilon waves, ventricular arrhythmias
- Action: Essential for diagnosis
2. Echocardiography (Essential)
- Purpose: Shows right ventricle changes
- Finding: Right ventricle dilation, dysfunction, regional wall motion abnormalities
- Action: Essential for diagnosis
Laboratory Tests
| Test | Expected Finding | Purpose |
|---|---|---|
| Genetic testing | May show mutation | Confirms diagnosis, family screening |
| BNP/NT-proBNP | May be elevated (if heart failure) | Assesses heart failure |
Imaging
Echocardiography (Essential):
| Indication | Finding | Clinical Note |
|---|---|---|
| All suspected cases | Right ventricle dilation, dysfunction | Diagnostic |
Findings:
- Right ventricle dilation: Enlarged right ventricle
- Regional wall motion abnormalities: Areas of dysfunction
- Reduced ejection fraction: If severe
Cardiac MRI (Essential):
| Indication | Finding | Clinical Note |
|---|---|---|
| All suspected cases | Fat infiltration, right ventricle changes | Diagnostic, gold standard |
Findings:
- Fat infiltration: Fat replaces muscle (characteristic)
- Right ventricle changes: Dilation, dysfunction
- Late gadolinium enhancement: Fibrosis
Holter Monitor (If Arrhythmias Suspected):
| Indication | Finding | Clinical Note |
|---|---|---|
| Arrhythmias suspected | Ventricular arrhythmias | Identifies arrhythmias |
Diagnostic Criteria
Task Force Criteria (2010):
- Major and minor criteria for diagnosis
- Categories: Imaging, tissue characterization, repolarization, depolarization, arrhythmias, family history/genetics
- Diagnosis: Requires meeting criteria
Severity Assessment:
- Mild: Minimal symptoms, good function
- Moderate: Arrhythmias, some dysfunction
- Severe: Heart failure, high risk of sudden death
Management Algorithm
SUSPECTED ARVC
(Young person + VT/syncope/family history)
↓
┌─────────────────────────────────────────────────┐
│ INVESTIGATIONS │
│ • ECG (characteristic changes) │
│ • Echocardiography (right ventricle changes) │
│ • Cardiac MRI (fat infiltration) │
│ • Genetic testing (if available) │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ DIAGNOSIS CONFIRMED │
│ • Task Force Criteria │
│ • Comprehensive assessment │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ RISK STRATIFICATION │
│ • Assess risk of sudden cardiac death │
│ • Consider: VT, syncope, family history, etc. │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ PREVENT SUDDEN DEATH │
│ • ICD implantation (if high risk) │
│ • This is the most important treatment │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ TREAT ARRHYTHMIAS │
│ • Antiarrhythmics (sotalol, amiodarone) │
│ • Catheter ablation (if recurrent VT) │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ TREAT HEART FAILURE (IF PRESENT) │
│ • ACE inhibitor, beta-blocker │
│ • Diuretics if fluid overload │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ LIFESTYLE MODIFICATIONS │
│ • Restrict competitive sports │
│ • May need to avoid high-intensity exercise │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ FAMILY SCREENING │
│ • Screen first-degree relatives │
│ • Genetic testing if mutation identified │
│ • ECG, echo, cardiac MRI │
└─────────────────────────────────────────────────┘
Acute/Emergency Management - The First Hour
Immediate Actions (Do Simultaneously):
-
If Sudden Cardiac Arrest
- Resuscitation: Immediate CPR, defibrillation
- Action: Save life first
-
If Ventricular Tachycardia
- Cardioversion: If unstable
- Antiarrhythmics: If stable
- Action: Restore normal rhythm
-
Assess Risk
- History: Family history, symptoms
- ECG: Characteristic changes
- Action: Assess risk of sudden death
-
ICD Consideration
- High risk: ICD implantation
- Action: Prevent sudden death
Medical Management
Antiarrhythmics:
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Sotalol | 80-160mg BD | Oral | Long-term | First-line |
| Amiodarone | 200-400mg OD | Oral | Long-term | Alternative |
| Beta-blocker | As appropriate | Oral | Long-term | Adjunct |
Heart Failure Treatment (If Present):
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| ACE inhibitor | As appropriate | Oral | Long-term | If heart failure |
| Beta-blocker | As appropriate | Oral | Long-term | If heart failure |
| Diuretics | As needed | Oral | As needed | If fluid overload |
Device Therapy
ICD Implantation (Essential if High Risk):
| Indication | Notes |
|---|---|
| Previous cardiac arrest | Essential |
| Sustained VT | Essential |
| Syncope | Consider |
| Family history of sudden death | Consider |
| Severe right ventricle dysfunction | Consider |
Mechanism: Prevents sudden cardiac death by detecting and treating dangerous arrhythmias
Catheter Ablation
Indication:
- Recurrent VT: Despite medications
- ICD shocks: Frequent shocks from ICD
Mechanism: Destroys areas causing arrhythmias
Disposition
Admit to Hospital If:
- Sudden cardiac arrest: Needs monitoring, ICD
- Sustained VT: Needs treatment, ICD
- Syncope: Needs assessment, may need ICD
Outpatient Management:
- Stable cases: Can be managed outpatient
- Regular follow-up: Monitor function, arrhythmias
Discharge Criteria:
- Stable: No active arrhythmias
- Clear plan: For ICD, medications, follow-up
Follow-Up:
- Regular: Monitor function, arrhythmias
- ICD checks: Regular ICD checks
- Family screening: Ongoing
Immediate (Days-Weeks)
| Complication | Incidence | Presentation | Management |
|---|---|---|---|
| Sudden cardiac death | 5-10% (if not treated) | Cardiac arrest | ICD prevents this |
| Ventricular tachycardia | 30-40% | Palpitations, syncope | Antiarrhythmics, ICD, ablation |
| Syncope | 20-30% | Fainting | Assess, may need ICD |
Sudden Cardiac Death:
- Mechanism: Ventricular fibrillation
- Management: ICD prevents this
- Prevention: ICD implantation
Early (Weeks-Months)
1. Heart Failure (20-30% over time)
- Mechanism: Progressive right ventricle dysfunction
- Management: Heart failure treatment, may need transplant
- Prevention: Early treatment, monitor function
2. Recurrent Arrhythmias (20-30%)
- Mechanism: Disease progression
- Management: Medications, ablation, ICD
- Prevention: Medications, monitor
Late (Months-Years)
1. Progressive Heart Failure (20-30%)
- Mechanism: Disease progresses, both ventricles affected
- Management: Heart failure treatment, may need transplant
- Prevention: Early treatment, monitor function
2. Left Ventricle Involvement (30-40% over time)
- Mechanism: Disease progresses to left ventricle
- Management: Treat as biventricular failure
- Prevention: Monitor, early treatment
Natural History (Without Treatment)
Untreated ARVC:
- High risk of sudden death: 5-10% per year
- Progressive heart failure: Over years
- Poor outcomes: If not treated
Outcomes with Treatment
| Variable | Outcome | Notes |
|---|---|---|
| Sudden death (with ICD) | <1% per year | ICD prevents sudden death |
| Survival | 80-90% at 10 years | With proper treatment |
| Heart failure | 20-30% over time | Progressive disease |
| Quality of life | Usually good | With proper management |
Factors Affecting Outcomes:
Good Prognosis:
- ICD implantation: Prevents sudden death
- Early diagnosis: Better outcomes
- No heart failure: Better outcomes
- Good compliance: With medications, follow-up
Poor Prognosis:
- No ICD (if high risk): High risk of sudden death
- Heart failure: Worse outcomes
- Recurrent arrhythmias: May affect quality of life
- Late diagnosis: May have more advanced disease
Prognostic Factors
| Factor | Impact on Prognosis | Evidence Level |
|---|---|---|
| ICD implantation | Prevents sudden death | High |
| Early diagnosis | Better outcomes | Moderate |
| Heart failure | Worse outcomes | High |
| Compliance | Better outcomes | Moderate |
Key Guidelines
1. ESC Guidelines (2015) — Ventricular arrhythmias and sudden cardiac death. European Society of Cardiology
Key Recommendations:
- ICD implantation if high risk
- Antiarrhythmics
- Family screening
- Evidence Level: 1A
Landmark Trials
Multiple studies on ICD efficacy, outcomes.
Evidence Strength
| Intervention | Level | Key Evidence | Clinical Recommendation |
|---|---|---|---|
| ICD implantation | 1A | Multiple studies | Essential if high risk |
| Antiarrhythmics | 1B | Studies | If arrhythmias |
| Family screening | 1A | Guidelines | Essential |
What is ARVC?
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart muscle disease where the muscle of your right ventricle (and sometimes left ventricle) is gradually replaced by fat and fibrous tissue. Think of your heart muscle as strong, contractile tissue—in ARVC, this tissue is replaced by fat and scar tissue, making your heart wall weak and prone to dangerous arrhythmias (ventricular tachycardia, ventricular fibrillation).
In simple terms: Your heart muscle is gradually replaced by fat and scar tissue, making your heart prone to dangerous arrhythmias and sudden cardiac death. This is a serious condition that needs lifelong management, but with proper treatment (especially an ICD), most people do well.
Why does it matter?
ARVC is a leading cause of sudden cardiac death in young people, especially athletes. Early recognition, proper diagnosis, and ICD implantation can prevent sudden death. The good news? With proper treatment (especially an ICD), most people do well and can live normal lives.
Think of it like this: It's like your heart muscle gradually being replaced by weaker tissue, making it prone to dangerous arrhythmias—an ICD can save your life if this happens.
How is it treated?
1. ICD Implantation (Most Important):
- What: An implantable cardioverter-defibrillator (ICD) is a device implanted in your chest that monitors your heart rhythm
- Why: If you have a dangerous arrhythmia, it can shock your heart back to normal rhythm, saving your life
- When: If you're at high risk of sudden cardiac death (previous cardiac arrest, VT, syncope, family history)
- This is the most important treatment: It prevents sudden cardiac death
2. Medications:
- Antiarrhythmics: Medicines to prevent arrhythmias (sotalol, amiodarone)
- Heart failure medicines: If you have heart failure (ACE inhibitors, beta-blockers)
- Why: To prevent arrhythmias and support your heart function
3. Catheter Ablation (If Needed):
- What: A procedure to destroy areas of your heart causing arrhythmias
- When: If you have recurrent VT despite medications
- Why: To reduce arrhythmias
4. Lifestyle Modifications:
- Restrict competitive sports: You may need to avoid high-intensity exercise
- Why: Exercise can trigger arrhythmias and may accelerate the disease
- Talk to your doctor: About what level of exercise is safe
5. Family Screening:
- Why: ARVC is inherited, so family members need to be screened
- What: ECG, echocardiography, cardiac MRI, genetic testing
- When: All first-degree relatives should be screened
The goal: Prevent sudden cardiac death (ICD), prevent arrhythmias (medications), and monitor your heart function.
What to expect
Management:
- ICD: You'll have an ICD implanted if you're at high risk
- Medications: You'll take medications long-term
- Follow-up: Regular follow-up to monitor your heart function and ICD
- Lifestyle: You may need to modify your exercise
After Treatment:
- ICD checks: Regular checks of your ICD (usually every 3-6 months)
- Medications: Continue medications as prescribed
- Monitoring: Regular tests to monitor your heart function
- Family screening: Family members will be screened
Long-Term:
- Most people do well: With proper treatment, most people live normal lives
- ICD protects you: The ICD can save your life if you have a dangerous arrhythmia
- Progressive disease: The disease may progress over time, but with monitoring and treatment, most people do well
When to seek help
Call 999 (or your emergency number) immediately if:
- You have sudden cardiac arrest (someone needs to call and start CPR)
- You have severe palpitations or feel like you're going to faint
- Your ICD shocks you (this means it detected a dangerous arrhythmia)
- You feel very unwell
See your doctor if:
- You have palpitations or feel your heart racing
- You have fainting episodes
- You have a family history of sudden cardiac death or ARVC
- You have concerns about your heart
Remember: If you have ARVC or are at risk, it's important to follow your doctor's advice, take your medications, and have regular follow-up. The ICD is life-saving—if you're at high risk, it's essential. Also, make sure family members are screened, as ARVC is inherited.
Primary Guidelines
- Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793-2867. PMID: 26320108
Key Trials
- Multiple studies on ICD efficacy and outcomes.
Further Resources
- ESC Guidelines: European Society of Cardiology
- ARVC Foundation: ARVC Foundation
Last Reviewed: 2025-12-25 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.